Fibertex Personal Care A/S – Trademark Portfolio
Entity Type: 99
Fibertex Personal Care A/S holds 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 24 (Fabrics) — 13 filings in this category. The portfolio also extends into Class 19 (Building Materials) across 5 Nice Classification classes. Currently, 5 trademarks are registered and 3 are pending. Notable registered marks include MDOF, FIBERTEX LOFT, FIBERTEX ELITE, FIBERTEX COMFORT, and FIBERTEX NONWOVENS.
Svendborgvej 2
DK-9220 Aalborg Ost
Showing of trademarks Trademarks
Trademark Classifications
Fibertex Personal Care A/S's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Building materials (non-metallic); non-metallic rigid pipes for building
Carpets, rugs, mats and matting, linoleum and other materials for covering floors
Frequently Asked Questions
How many trademarks does Fibertex Personal Care A/S have?
Fibertex Personal Care A/S has 13 U.S. trademarks filed with the USPTO. Of these, 5 registered, 3 pending.
What trademark classes does Fibertex Personal Care A/S file in?
Fibertex Personal Care A/S files trademarks across 5 Nice Classification classes. The most active classes are Class 24 (Fabrics), Class 19 (Building Materials), Class 27 (Floor Coverings), Class 17 (Rubber Goods), Class 12 (Vehicles). Class 24 covers textiles and textile goods; bed covers; table covers.
What are Fibertex Personal Care A/S's most well-known trademarks?
Fibertex Personal Care A/S's registered trademark portfolio includes well-known marks such as MDOF, FIBERTEX LOFT, FIBERTEX ELITE, FIBERTEX COMFORT, and FIBERTEX NONWOVENS. These are among 5 currently registered trademarks in the portfolio.
What is Fibertex Personal Care A/S's trademark registration success rate?
Fibertex Personal Care A/S has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 3 applications are pending review.